Published • loading... • Updated
Hepatitis C burden falls sharply among French drug users as antivirals
Summary by BIOENGINEER.ORG
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
Scienmag: Latest Science and Health NewsReposted by 
BIOENGINEER.ORG
BIOENGINEER.ORGHepatitis C burden falls sharply among French drug users as antivirals
A 20-year French surveillance study found that active hepatitis C infection among people who use drugs fell by half between 2013 and 2023, driven by direct-acting antiviral scale-up and harm reduction, though transmission continues above elimination targets.
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
